In this episode of The Digital Executive podcast, host Brian Thomas sits down with Tracy Wood, CEO of The DNA Company, to explore how functional genomics is reshaping personalized healthcare. Tracy shares the powerful personal story of her sister’s tragic passing that fueled her mission to reduce avoidable medical errors—one of the leading causes of death in the U.S. She discusses how pharmacogenomics (PGX) testing can prevent adverse drug reactions, reduce hospitalizations, and make precision medicine more accessible worldwide.

With a focus on innovation, patient-centered care, and affordability, Tracy explains The DNA Company’s groundbreaking approach to integrating genetic data, functional pathways, and patient history to deliver tailored health insights. She also highlights the company’s commitment to ongoing research, expanding gene reports, and providing continuous updates through a unique mobile app—ensuring patients benefit from the latest science without the need for retesting.

This conversation offers both a deeply personal perspective and a forward-looking vision of how functional genomics and precision medicine can save lives and transform healthcare globally.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.